Skip Navigation

Pfizer plans to charge nearly $1,400 for Paxlovid

Pfizer will list its COVID-19 treatment Paxlovid at a price of $1,390 per five-day course when it soon hits the commercial market, the drugmaker confirmed to Axios.

Why it matters: Paxlovid's new listed price, first reported by the Wall Street Journal, will be more than twice the $529 paid by the federal government, which until now has maintained the entire U.S. supply of the key antiviral medication.

60

You're viewing a single thread.

60 comments
You've viewed 60 comments.